Overview

A Study of MK-6552 in Sleep Deprived Healthy Participants (MK-6552-003)

Status:
COMPLETED
Trial end date:
2024-07-16
Target enrollment:
Participant gender:
Summary
This study examined the safety of the drug MK-6552 and if people tolerated it. It also studied whether MK-6552 works better than placebo for staying awake in sleep deprived healthy participants.
Phase:
PHASE1
Details
Lead Sponsor:
Merck Sharp & Dohme LLC
Treatments:
Modafinil